I think one of the things that people in general have, if they have multiple myeloma, generally they're older than other people. I think the average age is 69 years old, and most of us at that age suffer from a little bit of cognitive dysfunction, shall we say.
Now if you throw on a little bit of dexamethasone, thalidomide, melphalan, stem cell transplants, and that kind of thing, you have a little chemo brain along with that. Obviously, there is a cognitive issue that you've got to deal with.
The second thing is, on some of them — one of them which is an oral inhibitor is that most of people -- again, are in that 70-year-old age range, and because of that, they're on Medicare. When you're on Medicare, you do go through the doughnut hole, which is not that big a deal.
There's LLS that will cover the first $10,000, so if you happen to be on one oral medication, it's pretty much covered by the Leukemia and Lymphoma Society who also handles myeloma.
I think one of the things is to educate the patient on how to find this additional help with this medication, because I think it's a great one. I think it's better than the injection, and/or the IV, but the issue is going to be the cost. Now, the drug company can in fact provide as much as, and I think that they're going to do that, a lot of money for co-pay assistance, but that's only with commercial insurance.
Unfortunately, maybe 30 percent of the people with myeloma have commercial insurance. The rest have Medicare, so I think what we have is, we have a legislature that's just out of touch with the Medicare, and AARP generation, shall we say.
I don't quite understand it, why there's such a hole in it. It just makes no sense to me. I'd say something really negative about our law makers, but I think they've got plenty of that going on right now anyway.